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Interoffice Memorandum
SCHOOL OF PHARMACY
OFFICE OF THE DEAN
University, MS 38677
Phone: (662) 915-7265 Fax: (662) 915-5704
TO: All School of Pharmacy Personnel
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs
DATE: March 11, 2008
SUBJECT: Research News (#1)
The following GRANTS/CONTRACTS have recently been awarded:
1. Dr. Ameeta Agarwal (P.I. – National Center for Natural Products Research). Molecular Targets of
Novel Antifungal Compounds (National Institutes of Health/National Institute of Allergy and
Infectious Diseases), $192,053, September 20, 2007-August 31, 2008.
2. Dr. Bonnie Avery (P.I. – Pharmaceutics). UPLC-MS/MS Method Development of a New CoQ10
Prodrug (Chromadex, Inc.), $5,450, February 1, 2007-December 1, 2007.
3. Dr. Bonnie Avery (P.I. – Pharmaceutics). UPLC-MS/MS Method Development of a New CoQ10
Prodrug (Chromadex, Inc.), $1,860, February 1, 2007-December 1, 2007.
4. Dr. John Cleary (P.I. – Pharmacy Practice). Pharmaceutical Industry Report (Jones Microbiology
Institute), $2,000, August 2, 2007-December 31, 2011.
5. Dr. Robert Doerksen (P.I. – Medicinal Chemistry). Rational Computer-Aided Drug Design for
Glycogen Synthase Kinase-3 Inhibition (American Association of Colleges of Pharmacy/2007-2008
New Investigators Program), $10,000, December 15, 2007-December 15, 2008.
6. Dr. Daneel Ferreira (P.I. – Pharmacognosy). Oligomeric/Polymeric Procynanidins: Development of
Synthetic and Analytical Protocols  (Ocean Spray Cranberries, Inc.), $178,646, October 1, 2007-
October 1, 2008.
7. Dr. Daneel Ferreira (P.I. – Pharmacognosy). Microbial Transformation of Pomegranate Constituents
(POM Wonderful, LLC), $47,003, June 7, 2007-June 6, 2008.
8. Dr. Mark Hamann (P.I. – Pharmacognosy). Determining the Phytochemistry of Sweet Extracts from
Plant X2 (Kraft Foods, Inc.), $100,000, January 1, 2008-December 31, 2008.
9. Dr. Ikhlas Khan (P.I. – NCNPR); and Dr. Larry Walker (Co-P.I. – NCNPR). Science-Based
Authentication of Dietary Supplements (Food and Drug Administration), $1,610,000, July 1, 2007-
June 30, 2008.
10. Dr. Ikhlas Khan (P.I. – NCNPR); and Dr. David Pasco (Co-P.I. – NCNPR). Quality Assessment
of Botanicals (Herbalife), $100,000, July 1, 2007-June 30, 2008.
11. Dr. David Pasco (P.I. – NCNPR). Phase I PharmAfrican (PharmAfrican, Inc.), $18,553, February 2,
2008-July 30, 2008.
12. Dr. John Rimoldi (P.I. – Medicinal Chemistry). Semisynthesis of Marine Compounds (U. S.
Department of Commerce/ National Oceanic & Atmospheric Administration), $22,308, October 1,
2007-September 30, 2008.
13. Dr. Raymond Highsmith (P.I. – National Institute for Undersea Science and Technology); Dr. Marc
Slattery (P.I. – Pharmacognosy); and Dr. Robert Woolsey (Co-P.I. – Mississippi Mineral Resources
 
2Institute). The National Institute for Undersea Science and Technology Integrated Research and
Technology Development: Four-Year Science Plan and Proposal FY 2007-2011 (U.S. Dept. of
Commerce, National Oceanic and Atmospheric Administration [NOAA]), $3,300,000, October 1, 2007-
September 30, 2011.
14. Dr. Marc Slattery (P.I. – Pharmacognosy); and Dr. Deborah Gochfeld (Co-P.I. – NCNPR).
Modeling Seagrass Community Change Using Remote Sensing and Real-time Instrument Packages
(Mississippi State University/National Aeronautics and Space Administration), $229,403, July 1, 2007-
March 31, 2008.
15. Dr. Robert Speth (P.I. – Pharmacology). Inhibition of Angiotensin II – Induced Cardiac Fibrosis
(Phase IV) (University of Florida), $300, June 1, 2006-May 31, 2008.
16. Dr. Larry Walker (P.I. – NCNPR); Dr. Dhammika Nanayakkara (Co-P.I. – NCNPR); and Dr.
Babu Tekwani (Co-P.I. – NCNPR). Development of Safer Drugs for Malaria and Leishmaniasis in
U.S. Troops, Civilian Personnel and Travelers (U.S. Army Medical Research and Material Command),
$1,916,303, September 12, 2007-October 11, 2009.
17. Dr. Larry Walker (P.I. – NCNPR); and Dr. Ikhlas Khan (Co-P.I. – NCNPR). Discovery and
Development of Natural Product-Based Insect Management Compounds for Medical, Veterinary and
Urban, Concern (U.S. Department of Agriculture), $131,707, September 24, 2007-June 14, 2010.
18. Dr. Larry Walker (P.I. – NCNPR). Bioassays of Marine Compounds (U.S. Department of
Commerce/NOAA), $122,063, October 1, 2007-September 30, 2008.
19. Dr. Noel Wilkin (P.I. – Center for Pharmaceutical Marketing and Management); and Dr. William
Lobb (Co-P.I. – Center for Pharmaceutical Marketing and Management). Profiles in Innovation:
Community Pharmacists’ Adherence Program (National Community Pharmacists Association),
$20,000, August 20, 2007-December 31, 2007.
20. Dr. Kristine Willett (P.I. – Pharmacology/Environmental Technology Research Program). GOM
Ecotoxicology/Toxicity Assessment of Hurricane Katrina Impacted Sites (U.S. Department of
Commerce/NOAA), $30,845, October 1, 2007-September 30, 2008.
21. Dr. John Williamson (P.I. – Medicinal Chemistry); Dr. Mitchell Avery (Co-P.I. – Medicinal
Chemistry); Dr. Ronald Borne (Co-P.I. – Medicinal Chemistry); Dr. Christopher McCurdy (Co-
P.I. – Medicinal Chemistry);  and Dr. John Rimoldi (Co-P.I. – Medicinal Chemistry). IGERT –
Entrepreneurship at the Interface of Polymer Science and Medicinal Chemistry – Year 5 (The
University of Southern Mississippi/UM Joint Submission) (National Science Foundation), $322,120,
October 1, 2007-September 30, 2008.
22. Dr. Yu-Dong Zhou (P.I. – Pharmacognosy);  and Dr. Dale Nagle (Co-P.I. – Pharmacognosy).
Mechanistic Bioassays of Marine Compounds (U.S. Department of Commerce/NOAA), $75,400,
October 1, 2007-September 30, 2008.
23. Dr. Jordan Zjawiony (P.I. – Pharmacognosy). Diterpines as Selective Kappa Opioid Receptor
Agonists (Univ. of North Carolina at Chapel Hill/National Institutes of Health), $71,113, July 1, 2007-
June 30, 2008.
The following PUBLICATIONS have appeared:
1. Bharathi Avula, S. Dentali, and Ikhlas Khan, “Simultaneous Identification and Quantification by
Liquid Chromatography of Benzethonium Chloride, Methyl Paraben and Triclosan in Commercial
Products Labeled as Grapefruit Seed Extract”, Pharmazie, 62, 593-596 (2007).
2. Bharathi Avula, Zulfiqar Ali, and Ikhlas Khan, “Chemical Fingerprinting of Actaea racemosa
(Black Cohosh) and Its Comparison Study with Closely Related Actaea Species (A. pachypoda, A.
podocarpa, A. rubra) by HPLC”, Chromatographia, 66, 757-762 (2007).
3. Premalatha Balachandran and R. Govindarajan, “Ayurvedic Drug Discovery”, Expert Opinion
Drug Discovery, 2(12), 1631-1652 (2007).
4. Sunil Battu, Michael Repka, Soumyajit Majumdar, and M. Rao “Formulation and Evaluation of
Rapidly Disintegrating Fenoverine Tablets: Effect of Superdisintegrants”, Drug Development and
Industrial Pharmacy, 33, 1225-1232 (2007).
5. John Bowling, Anna Kochanowska, Noer Kasanah, and Mark Hamann, “Nature’s Bounty –
Drug Discovery from the Sea”, Expert Opinion Drug Discovery , 2(11), 1505-1522 (2007).
6. M. Chisholm, Barbara Wells, T.L. Schwinghammer, P. Malone, J. Kolesar, J. Rotschafer (eds),
Pharmacotherapy Principles and Practice, McGraw-Hill (2007).
37. Amar Chittiboyina, Gundluru Kumar, Paulo Carvalho, Yang Liu, Yu-Dong Zhou, Dale
Nagle, and Mitchell Avery, “Total Synthesis and Absolute Configuration of Laurenditerpenol: A
Hypoxia Inducible Factor-1 Activation Inhibitor”, Journal of Medicinal Chemistry (published on the
web 11/16/2007).
8. S.R. Choi, A. Pradhan, Nicholas Hammond, Amar Chittiboyina, Babu Tekwani, and Mitchell
Avery, “Design, Synthesis, and Biological Evaluation of Plasmodium falciparum  Lactate
Dehydrogenase Inhibitors”, Journal of Medicinal Chemistry, 50, 3841-3850 (2007).
9. S.R. Choi, A.B. Beeler, A. Pradhan, E.B. Watkins, John Rimoldi, Babu Tekwani, and Mitchell
Avery, “Generation of Oxamic Acid Libraries: Antimalarials and Inhibitors of Plasmodium
falciparum Lactate Dehydrogenase”, J. Comb. Chem., 9, 292-300 (2007).
10. Y.M. Choo, and Mark Hamann, “An Improved Pictet-Spengler Condensation: A Convenient
Synthetic Route to Bioactive Manzamine Derivatives”, Heterocycles, 71, 245-252 (2007).
11. M.M. Crowley, F. Zhang, Michael Repka, Sridhar Thumma, Sampada Upadhye, Sunil Battu,
J.W. McGinity, and C. Martin, “Pharmaceutical Applications of Hot-Melt Extrusion: Part I”, Drug
Development and Industrial Pharmacy, 33, 909-926 (2007).
12. J. Dai, Yang Liu, Hong Jia, Yu-Dong Zhou, and Dale Nagle, “Benzochromenones from the
Marine Crinoid Comantheria rotula Inhibit Hypoxia-Inducible Factor-1 (HIF-1) in Cell-Based
Reporter Assays and Differentially Suppress the Growth of Certain Tumor Cell Lines”, Journal of
Natural Products, 70, 1462-1466 (2007).
13. J. Dai, Yang Liu, Yu-Dong Zhou, and Dale Nagle, “Cytotoxic Metabolites from an Indonesian
Sponge Lendenfeldia sp.”, Journal of Natural Products, 70, 1824-1826 (2007).
14. Yuanqing Ding, Xing-Cong Li, and Daneel Ferreira, “Theoretical Calculation of Electronic
Circular Dichroism of the Rotationally Restricted 3,8”-Biflavonoid Morelloflavone”, Journal of
Organic Chemistry, 72, 9010-99017 (2007).
15. Wu Dong, and Kristine Willett, “Local Expression of CYP19A1 and CYP19A2 in Developing and
Adult Killifish (Fundulus heteroclitus)”, General and Comparative Endocrinology ,155, 307-317
(2007).
16. Mahmoud ElSohly, Waseem Gul, T.P. Murphy, Bharathi Avula, and Ikhlas Khan, “LC-(TOF)
MS Analysis of Benzodiazepines in Urine from Alleged Victims of Drug-Facilitated Sexual Assault”,
Journal of Analytical Toxicology, 31,  505-514 (2007).
17. Mahmoud ElSohly, and Waseem Gul, “Cannabinoids Analysis: Analytical Methods for Different
Biological Specimens”, Handbook of Analytical Separations, 6, 203-241 (2007).
18. Waseem Gul, Nicholas Hammond, M. Yousaf, Jiangnan Peng, A. Holley and Mark Hamann,
“Semisynthetic Studies of the Bioactive Marine Sesquiterpene (S)-(+)-Curcuphenol Isolated from a
Deep Reef Collection of Several Jamaican Sponges”, Biochimica and Biophysica Acta, 1770, 1513-
1519 (2007).
19. Mark Hamann, “The Manzamines as an Example of the Unique Structural Classes Available for the
Discovery and Optimization of Infectious Disease Controls Based on Marine Natural Products”,
Current Pharmaceutical Design, 13, 653-660 (2007).
20. Mark Hamann, D. Alonso, E. Martin-Aparacio, A. Fuertes, M.J. Perez-Puerto, A. Castro, S. Morales,
M.L. Navarro, M. del Monte-Millán, M. Medina, H. Pennaka, A. Balaiah, Jiangnan Peng, Jennifer
Cook, S. Wahyuono, and A. Martinez, “Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and
Structure-Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer’s
Disease”, Journal of Natural Products,70, 1397-1405 (2007).
21. Mark Hamann, R. Hill and S. Roggo Marine, “Natural Products Key Advances to the Practical
Application of this Resource in Drug Development”, Chimia, 61, 313-321 (2007).
22. Nickole Henyan, Daniel Riche, H.E. East, and P.N. Gann, “Impact of Statins on Risk of Stroke: A
Meta-Analysis”, The Annals of Pharmacotherapy, 41, 1937-1945 (2007).
23. H.M. Hua, Jiangnan Peng, D.C. Dunbar, R.F. Schinazi, A.G. de Castro Andrews, C. Cuevas, L.F.
Garcia-Fernandez, M. Kelly and Mark Hamann, “Batzelladine Alkaloids from the Caribbean Sponge
Monanchora unguifera and the Significant Activities Against HIV-1 AIDS Opportunistic Infectious
Pathogens”, Tetrahedron, 63, 11179-11188 (2007).
24. Vaishali Joshi, Bharathi Avula, and Ikhlas Khan, “Authentication of Stephania tetrandra S.
Moore (Fang Ji) and its Common Adulterant Using Mircro-morphology”, Journal of Natural
Medicine, 117-121 (2008).
425. T.J. Kim, Y. Lim, D.W. Kim, J.S. Kwon, J.H. Son, Y.R. Jin, D.J. Son, J.C. Jung, Mitchell Avery, J.T.
Hong, and Y.P. Yun, “Epothilone D, A Microtubule-Stabilizing Compound, Inhibits Neointimal
Hyperplasia after Rat Carotid Artery Injury by Cell Cycle Arrest via Regulation of G1-Checkpoint
Proteins”, Vascular Pharmacology, 47, 229-237 (2007).
26. Y. Lim, T.J. Kim, Y.R. Jin, D.W. Kim, J.S. Kwon, J.H. Son, J.C. Jung, Mitchell Avery, D.J. Son, J.T.
Hong, and Y.P. Yun, “Epothilone B Inhibits Neointimal Formation after Rat Carotid Injury through the
Regulation of Cell Cycle-Related Proteins”, The Journal of Pharmacology and Experimental
Therapeutics, 321, 648-655 (2007).
27. R. Liu, Yang Liu, Yu-Dong Zhou, and Dale Nagle, “Molecular-Targeted Antitumor Agents. 15.
Neolamellarins from the Marine Sponge Dendrilla nigra Inhibit Hypoxia-Inducible Factor-1
Activation and Secreted Vascular Endothelial Growth Factor Production in Breast Tumor Cells”,
Journal of Natural Products, 70, 1741-1745 (2007).
28. William Lobb, Noel Wilkin, David McCaffrey, Marvin Wilson, and John Bentley, “The
Predictive Value of a School of Origin Variable in Pharmacy Student Academic Performance”, Journal
of Pharmacy Teaching, 14, 79-97 (2007).
29. Vamsi Madgula, Bharathi Avula, Niranjan Reddy, Ikhlas Khan, and Shabana Khan,
“Transport of Decursin and Decursinol Angelate across Caco-2 and MDR-MDCK Cell Monolayers:
In vitro Models for Intestinal and Blood-Brain Barrier Permeability”, Planta Med. 73, 330-335 (2007).
30. Vamsi Madgula, Bharathi Avula, Y.W. Choi, S.V. Pullela, Ikhlas Khan, Larry Walker, and
Shabana Khan, “Transport of Schisandra chinensis Extract and its Biologically-Active Constituents
across Caco-2 Cell Monolayers – An in-vitro Model of Intestinal Transport”, Journal of Pharmacy
and Pharmacology, 60, 363-370 (2008).
31. A.M.S. Mayer, A.D. Rodriguez, R.G.S. Berlink and Mark Hamann, “Marine Pharmacology in
2003-2004: Marine Compounds with Anthelmintic, Antibacterial, Anticoagulant, Antifungal, Anti-
inflammatory, Antimalarial, Antiplatelet, Antiprotozoal, Antituberculosis, and Antiviral Activities;
Affecting the Cardiovascular, Immune and Nervous Systems, and Other Miscellaneous Mechanisms of
Action”, Comparative Biochemistry and Physiology, Part C, 145, 61, 553-581, (2007).
32. Ilias Muhammad, S. Takamatsu, J. Mustafa, Shabana Khan, Ikhlas Khan, Volodymyr
Samoylenko, J.S. Mossa, F.S. El-Feraly, and D.C. Dunbar, “COX-2 Inhibitory Activity of Cafestol
and Analogs from Coffee Beans”, Natural Product Communications, 3, 11-16 (2008).
33. Michael Repka, Sunil Battu, Sampada Upadhye, Sridhar Thumma, M.M. Crowley, F. Zhang,
C. Martin, and J.W. McGinity, “Pharmaceutical Applications of Hot-Melt Extrusion: Part II”, Drug
Development and Industrial Pharmacy, 33, 1043-1057 (2007).
34. Volodymyr Samoylenko, D.C. Dunbar, Melissa Jacob, Vaishali Joshi, Mohammad Ashfaq, and
Ilias Muhammad, “Two New Alkylated Piperidine Alkaloids from Western Honey Mesquite:
Prosopis glandulosa Torr. Var. torreyana”, Natural Product Communications, 3, 35-40 (2008).
35. A.G. Shilabin, Noer Kasanah, David Wedge and Mark Hamann, “Lysosome and HER3 (ErbB3)
Selective Anticancer Agent Kahalalide F: Semisynthetic Modifications and Antifungal Lead-
Exploration Studies”, Journal of Medicinal Chemistry, 50, 4340-4350 (2007).
36. N. Singh, G. Cheve, Mitchell Avery, and Christopher McCurdy, “Targeting the Methyl Erythritol
Phosphate (MEP) Pathway for Novel Antimalarial, Antibacterial and Herbicidal Drug Discovery:
Inhibition of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase (DXR) Enzyme”, Current
Pharmaceutical Design, 13, 1161-1177 (2007).
37. N. Singh, Mitchell Avery, and Christopher McCurdy, “Toward Mycobacterium Tuberculosis DXR
Inhibitor Design: Homology Modeling and Molecular Dynamics Simulations”, Journal of Computer-
Aided Molecular Design, 21, 511-522 (2007).
38. D.E. Stec, T. Vera, G.R. McLemore, S. Kelsen, John Rimoldi, R.S.V. Gadepalli, and M.J. Ryan,
“Heme Oxygenase-1 Induction Does Not Improve Vascular Relaxation in Angiotensin II Hypertensive
Mice”, American Journal of Hypertension, 2, 189-193 (2008).
39. Barbara Wells, “Dean’s Desk”, Mississippi Pharmacist, 33, 9-10 (2007).
40. J.D. Winkler, A.T. Londregan and Mark Hamann, “Synthetic Modification of Manzamine A via
Grubbs Metathesis Novel Structures with Enhanced Antibacterial and Antiprotozoal Properties”,
Organic Letters, 9 (2007).
541. Minghui Wu, A. Chaudhary, Ikhlas Khan, and Asok Dasmahapatra, “Ethanol Teratogenesis in
Japanese  Medaka: Effects at the Cellular Level”, Comparative Biochemistry and Physiology, Part B
(2007).
42. M. Zabalgoitia, J.T. Colston, S.V. Reddy, J.W. Holt, R.F. Regan, D.E. Stec, John Rimoldi, A.J.
Valente, B. Chandrasekar, “Carbon Monoxide Donors or Heme oxygenase-1 (HO-1) Overexpression
Blocks Interleukin-18-Mediated NF-kB-PTEN-Dependent Human Cardiac Endothelial Cell Death”,
Free Radical Biology & Medicine 44, 284-298 (2008).
43. Y. Zhang, Y.J. Zhang, Melissa Jacob, Xing-Cong Li, and C.R. Yang, “Steroidal Saponins from the
Stem of Yucca elephantipes”, Phytochemistry, 69, 264-270 (2008).
44. Shiqian Zhu, L. Li, Cammi Thornton, Paulo Carvalho, Bonnie Avery, and Kristine Willett,
“Simultaneous Determination of Benzo[a]pyrene and Eight of its Metabolites in Fundulus heteroclitus
Bile Using Ultra-Performance Liquid Chromatography with Mass Spectrometry”, Journal of
Chromatography, 863, 141-149 (2008).
TECHNOLOGY TRANSFER transactions:
(In the interest of protecting confidential information, the names and titles associated with School of
Pharmacy invention disclosures and patent applications will no longer be published until after a patent
has issued.)
Research Disclosures Filed in FY2007-2008: 11
U. S. Patent Applications Pending:  27
Recent U. S. Patents Granted:! Design and Synthesis of Optimized Ligands for PPAR; Avery,
Mitchell A; Pershadsingh; Harrihar A. U.S. Patent # 7,339,065
The following SPECIAL ANNOUNCEMENTS are also listed:
• The University of the Free State, in Bloemfontein, South Africa, will present Dr. Daneel Ferreira
with a doctorate degree during their graduation ceremony, April 23, 2008.  This honorary award is
in appreciation for his past and still ongoing affiliation, and to recognize the important role he has
played at the University.  Dr. Ferreira had a very influential career at the University until he joined
the National Center for Natural Products Research in the late 1990s.  He is still involved in some
ongoing projects there.
• Zlatko Mehmedic, Desmond Slade, Heather Denham, Don Stanford, Suman Chandra,
Ikhlas Khan, and Mahmoud ElSohly, presented “Indoor and Outdoor Cultivation of Cannabis:
Is There an Effect on the Chemical Composition of the Volatile Oil” at the International
Association for Cannabis as Medicine 4th Conference on Cannabinoids in Medicine, October 5-6,
2007 in Cologne, Germany.
Please continue to send me important research and graduate information so that I might share it with your
faculty colleagues.
This information is now being posted on the School of Pharmacy web page
(www.pharmacy.olemiss.edu).
cc: Dean Barbara G. Wells
Ms. Dabney Weems
Ms. Julie Edgington, Office of Research
